Nutex Health Inc. (NUTX) company profile
Close on Nov 13, 2026Market cap $1.19BP/E 7.4Yield –
About Nutex Health
Services-Business Services, NEC, SIC 7389
Nutex Health Inc. is a physician-led healthcare services and operations company. It structures its operations into three primary segments: the hospital division, the population health management division, and the real estate division. Through its hospital division, the company develops and operates micro-hospitals, specialty hospitals, and hospital outpatient departments that provide emergency room care, inpatient treatment, behavioral health, and ancillary services including diagnostic imaging, laboratories, and onsite pharmacies. The population health management division organizes and manages provider networks known as independent physician associations via a management services organization. The company serves patients seeking emergency and primary medical care, receiving reimbursement primarily from health insurers, federal agencies, and patient cost-sharing payments.
The company operates 26 healthcare facilities across 12 U.S. states and oversees four independent physician associations serving members across California, Florida, Texas, and Arizona. Its operational workforce comprises 944 full-time employees, over 280 contracted facility doctors, and partnerships with more than 3,600 network physicians and specialists. Nutex Health maintains its corporate headquarters in Houston, Texas.
Summary of the business section of Nutex Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Nutex Health Inc.
- Founded
- 2000
- Headquarters
- Houston, TX
- Address
- 1776 Yorktown St, Suite 700 77056
- Phone
- (713) 660-0557
- Website
- www.nutexhealth.com
- Employees
- 944, Dec 31, 2025
- Industry
- Services-Business Services, NEC
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Marcum LLP, Houston, Texas
Stock & identifiers
- Ticker
- NUTX
- Former tickers
- CLNH until Apr 4, 2022; IGMB until Aug 16, 2021; IGAM until Apr 14, 2016
- Exchange
- Nasdaq
- IPO date
- Apr 4, 2022
- Shares outstanding
- 7M, Aug 4, 2026
- Public float
- $524.00M, Jun 30, 2025
- Filer category
- Accelerated filer
- Stock splits
- 1-for-10 reverse, Jul 3, 2024; 1-for-15 reverse, Apr 10, 2024; 20-for-1, Aug 22, 2022; 1-for-500 reverse, Nov 19, 2019
- SEC CIK
- 1479681
- CUSIP
- 67079U306
- ISIN
- US67079U3068
- FIGI
- BBG000PQN2M0
- Share class FIGI
- BBG001T5W5K5
- LEI
- 254900RSD2OET3HENJ50
- EIN
- 11-3363609
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Thomas T. Vo | Chief Executive Officer, Director | 28,809,974 |
| Warren Hosseinion | President, Director | 61,739 |
| Wesley Shane Bamburg | Chief Operating Officer | – |
| Pamela W. Montgomery | Chief Legal Officer-Healthcare | 2,758 |
| Michael L. Chang | Chief Medical Officer | 82,356 |
| Elisa V. Luqman | Chief Legal Officer - SEC | 4,224 |
| Jon Christian Bates | Chief Financial Officer | 8,305 |
| Joshua DeTillio | Chief Operating Officer | 6,481 |
| Scott J. Saunders | Director | 400 |
| Cheryl Yvonne Grenas | Director | 10,670 |
| Frank E. Jaumot | Director | 753 |
| Michael Lee Reed | Director | 670 |
| Kelvin Spears | Director | 34,656 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $1.94M | $4.60M | $787.81K | $58 | $122 |
| FY2024 | $1.16M | $1.56M | $912.23K | $11 | $106 |
| FY2023 Thomas T. Vo | $1.02M | $1.02M | $577.39K | $9 | $103 |
| FY2023 Tom Vo | $1.01M | $1.01M | $577.39K | $9 | $103 |
| FY2022 Dr Hosseinion | $2.67M | $2.19M | $419.42K | $-450 | – |
| FY2022 Dr Vo | $938.23K | $938.23K | $419.42K | $-450 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Thomas T. Vo Chief Executive Officer (1) | $1.00M | $504.88K | $669.95K | $22.59K | $2.20M | +232% |
| Warren Hosseinion President (2) | $755.10K | $382.43K | $505.91K | $61.99K | $1.71M | +97% |
| Jon Bates Chief Financial Officer (3) | $350.00K | $279.88K | $239.67K | $54.66K | $923.21K | +127% |
| Wesley Bamburg Current Chief Operating Officer (4) | $79.81K | $25.00K | – | $1.16K | $105.97K | – |
| Joshua DeTillio Former Chief Operating Officer (5) | $269.71K | $297.50K | $354.68K | $30.24K | $952.13K | +86% |
| Michael Chang Chief Medical Officer 6) | $394.23K | $129.88K | $167.49K | $24.99K | $716.59K | +140% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
Corporate history
Events identified from SEC filings
See a number that looks wrong?